Page last updated: 2024-12-08
dimethylethylsilylimidazole
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
dimethylethylsilylimidazole: used in gas chromatography [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 173854 |
SCHEMBL ID | 918580 |
MeSH ID | M0177458 |
Synonyms (18)
Synonym |
---|
dimethylethylsilylimidazole |
FT-0693246 |
62365-34-8 |
D1516 |
1-(dimethylethylsilyl)imidazole |
ethyl-imidazol-1-yl-dimethylsilane |
AKOS006229017 |
einecs 263-525-6 |
1-(ethyldimethylsilyl)-1h-imidazole |
SCHEMBL918580 |
mfcd00059723 |
1-ethyldimethylsilylimidazole |
1-(dimethylethylsilyl)imidazole [dimethylethylsilylating agent] |
1-(dimethylethylsilyl)inidazole |
DTXSID10977911 |
1-[ethyl(dimethyl)silyl]-1h-imidazole |
T71136 |
BS-23532 |
Research Excerpts
Pharmacokinetics
Excerpt | Reference | Relevance |
---|---|---|
" NAFLD may affect the pharmacokinetic parameters." | ( The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice. Bai, Z; Chen, L; He, Y; Qin, L; Song, Y; Tan, D; Wang, YH; Zhu, Y, 2023) | 0.91 |
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" These results led us to wonder whether current drug dosage recommendations may need to be reevaluated." | ( The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice. Bai, Z; Chen, L; He, Y; Qin, L; Song, Y; Tan, D; Wang, YH; Zhu, Y, 2023) | 0.91 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 9 (90.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.05
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.05) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 3 (30.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (70.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |